Royal Philips (NYSE:PHG) recently announced the launch of its Medical Tablet in North America, Europe and Japan. The Philips Medical Tablet is meant to provide remote access to patient data. The goal is to allow health providers to improve workflows and better manage increases in patient volume. A fully portable setup is possible for the remote […]
TransEnterix brings in $79.6M from stock offering
TransEnterix (NYSE:TRXC) recently announced that it has closed on a public offering of more than 26.5 million shares of its common stock, with roughly $79.6 million in aggregate gross proceeds for the surgical robotics company. The offering, in combination with recent financing activity, extends TransEnterix’s cash runway into 2024. The money will go toward general corporate […]
BioSig, Mayo Clinic announce AI development partnership
BioSig Technologies (NSDQ:BSGM) will work with the Mayo Foundation for Medical Education and Research to develop next-gen, AI-powered software for its Pure EP system, which is meant to take electrophysiology to the next level. The Mayo Clinic has already been an important investor and development partner for the Westport, Conn.–based company. BioSig signed a 10-year collaboration […]
CooperSurgical acquires Aegea Medical and its water vapor ablation system
CooperCompanies’ (NYSE:COO) CooperSurgical business has purchased Aegea Medical, nearly a year after Aegea secured FDA approval for its Mara water vapor ablation system for treating heavy menstrual bleeding. The financial terms of the deal were not disclosed in the companies’ announcement yesterday. The companies pointed out an international, multi-center pivotal clinical trial enrolling 155 women, […]
3M, Abbott in top 50 of Fortune’s most admired companies list
Medtech giants 3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list. 3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. […]
The top 5 MassDevice stories of the week — January 29, 2021
Two important medtech industry hires are among the top stories on MassDevice this week, with robotic surgery and COVID-19 vaccines also dominating the news. Want to hear more about the week’s top medtech news on MassDevice? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” — as well as play some drum […]
Edwards Lifesciences misses on earnings in Q4
Edwards Lifesciences (NYSE:EW) posted fourth-quarter earnings this evening that missed the consensus forecast on Wall Street, though the company met revenue expectations. The Irvine, Calif.–based cardio device company reported profits of $309.5 million, or 49¢ per share, on sales of $1.19 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 10.5% […]
Stryker beats the Street on earnings but misses on revenue in Q4
Stryker (NYSE:SYK) posted fourth-quarter earnings this evening that beat the consensus forecast on Wall Street, but the company missed slightly on revenue. The Kalamazoo, Mich.–based orthopedic device giant — the world’s largest — reported profits of $568 million, or $1.49 per share, on sales of $4.262 billion for the three months ended Dec. 31, 2020, for […]
Titan Medical closes on $11.5M offering
Titan Medical (TSX:TMD; NSDQ:TMDI) announced today that it has closed on a previously announced offering, raising $11.5 million in aggregate gross proceeds. The Toronto-based surgical robotics company conducted the sale by way of a short form prospectus in each of the provinces of British Columbia, Alberta and Ontario — as well as a private placement in […]
BD CEO Polen to also serve as board chair
Tom Polen, the CEO of Becton Dickinson (NYSE:BDX), will also serve as BD’s board chair effective April 28, the company said today. Polen takes over the board chair slot from former CEO Vincent A. Forlenza, who will retire at that time. Polen, 47, has held the corner office at BD since January 2020. He joined […]
Johnson & Johnson pharma sales drive Street-beating Q4 results
Johnson & Johnson (NYSE:JNJ) posted fourth-quarter results today that beat the consensus forecast on Wall Street — with the company predicting a return to strong sales growth in 2021. The New Brunswick, N.J.–based pharma, medical device and consumer products giant reported profits of $1.7 billion, or 65¢ per share, on sales of $22.5 billion for the […]